These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 8438435

  • 1. Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients.
    Wilkie ME, Beer JC, Raftery MJ, Dawnay A, Barton C, Marsh FP.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):612-5. PubMed ID: 8438435
    [No Abstract] [Full Text] [Related]

  • 2. Long-term effects of cyclosporine on hemodynamic parameters of renal allograft recipients.
    Abbud-Filho M, Barberato JB, Ramalho HJ, Salgueiro MC, Yamazaki WM, Paiva EV, Corrente JE, Bezas AG.
    Transplant Proc; 1992 Oct; 24(5):1722-3. PubMed ID: 1412810
    [No Abstract] [Full Text] [Related]

  • 3. Effects of different immunosuppressive protocols on renal hemodynamics of transplanted patients.
    Abbud-Filho M, Barberato JB, Ramalho HJ, Yamazaki WM, Salgueiro MC, Silva ML, Ribeiro AC, Bezas AG.
    Transplant Proc; 1994 Oct; 26(5):2594-5. PubMed ID: 7940805
    [No Abstract] [Full Text] [Related]

  • 4. The beneficial effects of isradipine on renal hemodynamics in cyclosporine-treated renal transplant recipients.
    McCrea JB, Francos GF, Burke JF, Michael HJ, Besarab A.
    Transplantation; 1993 Mar; 55(3):672-4. PubMed ID: 8456491
    [No Abstract] [Full Text] [Related]

  • 5. The effect of cyclosporine and azathioprine on GFR and renal histopathology 12 to 24 months after renal transplantation.
    Pedersen EB, Hansen HE, Olsen S.
    Transplant Proc; 1992 Feb; 24(1):309-10. PubMed ID: 1539289
    [No Abstract] [Full Text] [Related]

  • 6. Elective conversion from cyclosporine to azathioprine and prednisolone in patients after cadaveric renal transplantation: observations on graft survival and renal function.
    Tegzess AM, van Son WJ, de Maar EF, Beelen JM, Sluiter WJ, Huisman RM.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1635-7. PubMed ID: 2652534
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Five years' follow-up of renal glomerular and tubular functions in heart transplant recipients.
    Hartmann A, Andereassen AK, Holdaas H, Simonsen S, Geiran O, Berg KJ.
    J Heart Lung Transplant; 1996 Oct; 15(10):972-9. PubMed ID: 8913913
    [Abstract] [Full Text] [Related]

  • 10. Renal effects of L-arginine infusion in cyclosporine-treated transplant recipients.
    Viganò E, Badalamenti S, Paone G, Como G, Finazzi S, Tarantino A, Galmarini D, Ponticelli C.
    Transplant Proc; 1994 Oct; 26(5):2622-3. PubMed ID: 7940816
    [No Abstract] [Full Text] [Related]

  • 11. Prospective randomised study of the influence of cyclosporin on long-term renal allograft function.
    Rowe PA, Watson MA, McMillan MA, Briggs JD, Rodger RS, Junor BJ.
    Transplant Proc; 1994 Oct; 26(5):2617-8. PubMed ID: 7940814
    [No Abstract] [Full Text] [Related]

  • 12. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies.
    Pedersen EB, Madsen JK, Sørensen SS, Zachariae H.
    Kidney Int Suppl; 1996 Jun; 55():S94-6. PubMed ID: 8743522
    [Abstract] [Full Text] [Related]

  • 13. Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients.
    Wahlberg J, Hanås E, Bergström C, Fellström B, Skarp-Orberg I, Frödin L.
    Transplant Proc; 1992 Feb; 24(1):311-2. PubMed ID: 1539291
    [No Abstract] [Full Text] [Related]

  • 14. Evolution of glomerular filtration rate and renal plasma flow in cyclosporine-treated heart transplant recipients over a 1-year period.
    Lloveras JJ, Durand D, Ader JL, Tran Van T, Rostaing L, Cerene A, Fournial G, Suc JM.
    Transplant Proc; 1993 Jun; 25(3):2226. PubMed ID: 8516879
    [No Abstract] [Full Text] [Related]

  • 15. Enalapril and cyclosporin in renal transplant patients and rats.
    Ferguson CJ, von Ruhland C, Shrestha B, Griffin PJ, Moore RH, Salaman JR.
    Transplant Proc; 1994 Oct; 26(5):2600-1. PubMed ID: 7940808
    [No Abstract] [Full Text] [Related]

  • 16. The Neoral formulation: improved correlation between cyclosporine trough levels and exposure in stable renal transplant recipients.
    Kahan BD, Dunn J, Fitts C, Van Buren D, Wombolt D, Pollak R, Carson R, Alexander JW, Chang C, Choc M.
    Transplant Proc; 1994 Oct; 26(5):2940-3. PubMed ID: 7940928
    [No Abstract] [Full Text] [Related]

  • 17. Does alpha 1 microglobulin in urine predict renal function after transplantation?
    Preuss R, Riek R, Steinhoff J, Fricke L, Hoyer J, Sack K.
    Transplant Proc; 1994 Jun; 26(3):1766-7. PubMed ID: 7518157
    [No Abstract] [Full Text] [Related]

  • 18. Randomized controlled trial of complete steroid withdrawal in renal transplant patients receiving triple immunosuppression.
    Ratcliffe PJ, Firth JD, Higgins RM, Smith B, Gray DW, Morris PJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):590. PubMed ID: 8438427
    [No Abstract] [Full Text] [Related]

  • 19. Follow-up of 29 kidney transplant recipients having more than 20 years of functioning allografts.
    Fonseca JA, Ianhez LE, Azevedo LS, Sabbaga E.
    Transplant Proc; 1992 Oct; 24(5):1863-4. PubMed ID: 1412886
    [No Abstract] [Full Text] [Related]

  • 20. Calcium antagonist therapy prevents chronic cyclosporine nephrotoxicity after renal transplantation: a prospective study.
    Morales JM, Andres A, Rodriguez Paternina E, Alcazar JM, Montoyo C, Rodicio JL.
    Transplant Proc; 1992 Feb; 24(1):89-91. PubMed ID: 1347185
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.